
Tarsus Pharmaceuticals Inc (TARS)
NASDAQ
Fin d'année 31 Décembre 2024 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -110.423 | -15.386 | -23.285 | -7.881 | -30.529 | -55.089 | -35.971 |
Return on Equity (%) | 194.83 | 126.919 | -33.519 | -8.312 | -34.53 | -69.709 | -54.827 |
Return on Invested Capital (%) | -122.265 | -14.426 | -24.183 | -7.364 | -33.268 | -65.602 | -46.891 |
Operating Margin (%) | N/A | N/A | N/A | -24.15 | -232.011 | -759.712 | -58.87 |
Net Profit Margin (%) | N/A | N/A | N/A | -24.246 | -240.514 | -778.89 | -63.16 |
Book Value Per Share | 1.063 | 21.684 | 8.167 | 8.055 | 7.217 | 5.834 | 5.656 |
Earnings Per Share | -0.634 | -1.764 | -1.319 | -0.668 | -2.323 | -4.105 | -3.023 |
Cash Per Share | 1.133 | 21.893 | 8.273 | 8.277 | 2.681 | 6.795 | 2.48 |
Working Capital Per Share | 1.06 | 21.614 | 8.132 | 7.946 | 7.855 | 6.621 | 7.222 |
Operating Profit Per Share | N/A | N/A | N/A | 2.655 | 0.93 | 0.479 | 4.45 |
EBIT Per Share | -0.634 | -1.764 | -1.319 | -0.665 | -2.323 | -4.105 | -3.023 |
EBITDA Per Share | -0.634 | -1.764 | -1.319 | -0.665 | -2.323 | -4.105 | -3.023 |
Free Cash Flow Per Share | -0.632 | -1.712 | -1.302 | -0.655 | -2.316 | -3.965 | -2.883 |
Fin d'année 31 Décembre 2024 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 2,08M | 2,65M | 20,32M | 20,7M | 26,73M | N/A | N/A |
Fin d'année 31 Décembre 2024 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -909.4 | N/A | N/A | N/A | -125.835 | N/A | N/A | N/A |
Net Profit Margin (%) | -936.76 | N/A | N/A | N/A | -129.395 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,94B |
Ratio cours/bénéfice | -17,17 |
Ratio prix/ventes | 10,84 |
Ratio prix/liquidités | 20,92 |
Ratio prix/valeur comptable | 8,83 |
Rendement de dividende | - |
Actions en circulation | 38,38M |
Volume moyen (1 semaine) | 855,17k |
Volume moyen (1 mois) | 682,88k |
Variation sur 52 semaines | 51,07% |
Plus haut sur 52 semaines | 57,28 |
Plus bas sur 52 semaines | 20,0818 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales